CPT 527U — Herpes simplex virus (HSV) types 1 and 2 and Varicella zoster virus (VZV), amplified probe technique, each pathogen reported as detected or not detected (12 hospitals, — samples)
CPT 528T — PRGRMG DEV EVAL IIMS IP (12 hospitals, — samples)
CPT 528U — Lower respiratory tract infectious agent detection, 18 bacteria, 8 viruses, and 7 antimicrobial-resistance genes, amplified probe technique, including reverse transcription for RNA targets, each analyte reported as detected or not detected with semiquanti (12 hospitals, — samples)
CPT 529T — INTERROG DEV EVAL IIMS IP (12 hospitals, — samples)
CPT 529U — Hematology (venous thromboembolism [VTE]), genome-wide single-nucleotide polymorphism variants, including F2 and F5 gene analysis, and Leiden variant, by microarray analysis, saliva, report as risk score for VTE (12 hospitals, — samples)
CPT 532U — Rare diseases (constitutional disease/hereditary disorders), rapid whole genome and mitochondrial DNA sequencing for single-nucleotide variants, insertions/deletions, copy number variations, peripheral blood, buffy coat, saliva, buccal or tissue sample, r (1 hospital, — samples)
CPT 533T — Continuous Recording Of Movement Disorder Symptoms For 8-10 Days With Set-Up, Patient Training, Configuration Of Monitor, Upload Of Data , Analysis And Initial Report Configuration, Download Of Review, Interpretation And Report (1 hospital, — samples)
CPT 533U — Drug metabolism (adverse drug reactions and drug response), genotyping of 16 genes (ie, ABCG2, CYP2B6, CYP2C9, CYP2C19, CYP2C, CYP2D6, CYP3A5, CYP4F2, DPYD, G6PD, GGCX, NUDT15, SLCO1B1, TPMT, UGT1A1, VKORC1), reported as metabolizer status and transporter (1 hospital, — samples)
CPT 53451 — TPRNL BALO CNTNC DEV BI (1 hospital, — samples)
CPT 53452 — TPRNL BALO CNTNC DEV UNI (1 hospital, — samples)
CPT 53453 — TPRNL BALO CNTNC DEV RMVL EA (1 hospital, — samples)
CPT 534T — Continuous Recording Of Movement Disorder Symptoms For 8-10 Days With Set-Up, Patient Training, Configuration Of Monitor (1 hospital, — samples)
CPT 534U — Oncology (prostate), microRNA, single-nucleotide polymorphisms (SNPs) analysis by RT-PCR of 32 variants, using buccal swab, algorithm reported as a risk score (1 hospital, — samples)
CPT 535T — Continuous Recording Of Movement Disorder Symptoms For 8-10 Days With Data Upload, Analysis And Initial Report Configuration (1 hospital, — samples)
CPT 535U — Perfluoroalkyl substances (PFAS) (eg, perfluorooctanoic acid, perfluorooctane sulfonic acid), by liquid chromatography with tandem mass spectrometry (LC-MS/MS), plasma or serum, quantitative (1 hospital, — samples)
CPT 536U — Red blood cell antigen (fetal RhD), PCR analysis of exon 4 of RHD gene and housekeeping control gene GAPDH from whole blood in pregnant individuals at 10+ weeks gestation known to be RhD negative, reported as fetal RhD status (1 hospital, — samples)
CPT 537U — Oncology (colorectal cancer), analysis of cell-free DNA for epigenomic patterns, next-generation sequencing, >2500 differentially methylated regions (DMRs), plasma, algorithm reported as positive or negative (1 hospital, — samples)
CPT 53865 — CYSTOURETHROSCOPY WITH INSERTION OF TEMPORARY DEVICE FOR ISCHEMIC REMODELING (IE, PRESSURE NECROSIS) OF BLADDER NECK AND PROSTATE (2 hospitals, — samples)
CPT 53866 — CATHETERIZATION WITH REMOVAL OF TEMPORARY DEVICE FOR ISCHEMIC REMODELING (IE, PRESSURE NECROSIS) OF BLADDER NECK AND PROSTATE (1 hospital, — samples)
CPT 538U — Oncology (solid tumor), next-generation targeted sequencing analysis, formalin-fixed paraffin-embedded (FFPE) tumor tissue, DNA analysis of 600 genes, interrogation for single-nucleotide variants, insertions/deletions, gene rearrangements, and copy number (1 hospital, — samples)
CPT 539U — Oncology (solid tumor), cell-free circulating tumor DNA (ctDNA), 152 genes, next-generation sequencing, interrogation for single-nucleotide variants, insertions/deletions, gene rearrangements, copy number alterations, and microsatellite instability, using (1 hospital, — samples)
CPT 53U — Fish Analysis Of 4 Genes In Prostate Needle Biopsy Specimen (1 hospital, — samples)
CPT 540 — ANESTH CHEST SURGERY (12 hospitals, — samples)
CPT 540U — Transplantation medicine, quantification of donor-derived cell-free DNA using next-generation sequencing analysis of plasma, reported as percentage of donor-derived cell-free DNA to determine probability of rejection (1 hospital, — samples)
CPT 541T — MYOCARDIAL IMAGING MCG (12 hospitals, — samples)
CPT 541U — Cardiovascular disease (HDL reverse cholesterol transport), cholesterol efflux capacity, LC-MS/MS, quantitative measurement of 5 distinct HDL-bound apolipoproteins (apolipoproteins A1, C1, C2, C3, and C4), serum, algorithm reported as prediction of corona (1 hospital, — samples)
CPT 542U — Nephrology (renal transplant), urine, nuclear magnetic resonance (NMR) spectroscopy measurement of 84 urinary metabolites, combined with patient data, quantification of BK virus (human polyomavirus 1) using real-time PCR and serum creatinine, algorithm re (1 hospital, — samples)
CPT 543U — Oncology (solid tumor), next-generation sequencing of DNA from formalin-fixed paraffin-embedded (FFPE) tissue of 517 genes, interrogation for single- nucleotide variants, multi-nucleotide variants, insertions and deletions from DNA, fusions in 24 genes an (1 hospital, — samples)
CPT 544U — Nephrology (transplant monitoring), 48 variants by digital PCR, using cell-free DNA from plasma, donor-derived cell-free DNA, percentage reported as risk for rejection (1 hospital, — samples)